Understanding the failure of CD8 T-cell vaccination against simian/human immunodeficiency virus
暂无分享,去创建一个
[1] Louis J. Picker,et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.
[2] Rustom Antia,et al. Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.
[3] L. Segel,et al. Extending the quasi-steady state approximation by changing variables. , 1996, Bulletin of mathematical biology.
[4] R. Desrosiers,et al. Immunization of Macaques with Single-Cycle Simian Immunodeficiency Virus (SIV) Stimulates Diverse Virus-Specific Immune Responses and Reduces Viral Loads after Challenge with SIVmac239 , 2005, Journal of Virology.
[5] Philip J. R. Goulder,et al. HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.
[6] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[7] R. Steinman,et al. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum. , 2007, Frontiers in bioscience : a journal and virtual library.
[8] D. Montefiori,et al. Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge , 1999, Journal of Virology.
[9] Alan S. Perelson,et al. Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.
[10] Philippa Marrack,et al. Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.
[11] M. Nowak,et al. Virus dynamics: Mathematical principles of immunology and virology , 2001 .
[12] Gary J. Nabel,et al. Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys , 2006, Science.
[13] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[14] G. Griffiths,et al. The immunological synapse of CTL contains a secretory domain and membrane bridges. , 2001, Immunity.
[15] A. Lackner,et al. HIV swiftly guts the immune system , 2005, Nature Medicine.
[16] D. Montefiori,et al. A Combination DNA and Attenuated Simian Immunodeficiency Virus Vaccine Strategy Provides Enhanced Protection from Simian/Human Immunodeficiency Virus-Induced Disease , 2005, Journal of Virology.
[17] J. Mcghee,et al. HIV infection: first battle decides the war. , 2006, Trends in immunology.
[18] Kendall C. Krebs,et al. Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus Macaques , 2005, Journal of Virology.
[19] Todd M. Allen,et al. Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication , 2002, Journal of Virology.
[20] James G. Herndon,et al. Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine , 2001, Science.
[21] A. Khoruts,et al. Naïve and Memory CD4+ T Cell Survival Controlled by Clonal Abundance , 2006, Science.
[22] Sebastian Bonhoeffer,et al. Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.
[23] A S Perelson,et al. Target cell limited and immune control models of HIV infection: a comparison. , 1998, Journal of theoretical biology.
[24] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[25] Rolf M. Zinkernagel,et al. What is missing in immunology to understand immunity? , 2000, Nature Immunology.
[26] B. M. Flynn,et al. Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment , 2001, Journal of Virology.
[27] L. Cauley,et al. Antiviral memory T-cell responses in the lung. , 2002, Microbes and infection.
[28] David Montefiori,et al. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[30] Ralph Weissleder,et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. , 2006, Immunity.
[31] Kristin Beaudry,et al. Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys , 2003, Journal of Virology.
[32] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[33] David C Montefiori,et al. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants , 2005, Nature Immunology.
[34] Qingsheng Li,et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.
[35] P D Griffiths,et al. Population dynamics of HIV within an individual after treatment with zidovudine , 1991, AIDS.
[36] A S Perelson,et al. Resource competition determines selection of B cell repertoires. , 2001, Journal of theoretical biology.
[37] A S Perelson,et al. Towards a general function describing T cell proliferation. , 1995, Journal of theoretical biology.
[38] Dominik Wodarz,et al. Contrasting B cell- and T cell-based protective vaccines. , 2005, Journal of theoretical biology.
[39] M. Nowak,et al. Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Watkins,et al. Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.
[41] Wei Lu,et al. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection , 2004, Nature Medicine.
[42] Mario Roederer,et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.
[43] P. Kahn. Susceptibility Genes: Pointing a Way to Prevention? , 1996, Science.
[44] Philippa Marrack,et al. T cells down-modulate peptide-MHC complexes on APCs in vivo , 2002, Nature Immunology.
[45] Katrina Walsh,et al. Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost , 2005, Journal of Virology.
[46] S. Staprans,et al. bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on March 1, 2013. For personal use , 2006 .
[47] Dominik Wodarz,et al. Direct quantitation of rapid elimination of viral antigen‐positive lymphocytes by antiviral CD8+ T cells in vivo , 2000, European journal of immunology.
[48] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[49] J. Flamm,et al. Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.
[50] Philippa Marrack,et al. T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells , 2000, The Journal of experimental medicine.
[51] R. Zinkernagel,et al. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Desrosiers,et al. Protective immunity induced by live attenuated simian immunodeficiency virus. , 1998, Current opinion in immunology.
[53] Otto O. Yang,et al. How Many Human Immunodeficiency Virus Type 1-Infected Target Cells Can a Cytotoxic T-Lymphocyte Kill? , 2005, Journal of Virology.
[54] F. Miedema,et al. T cell dynamics in HIV-1 infection. , 1999, Advances in immunology.
[55] Sergei S. Pilyugin,et al. Modeling immune responses with handling time , 2000, Bulletin of mathematical biology.
[56] P. Doherty,et al. The Collagen Binding α1β1 Integrin VLA-1 Regulates CD8 T Cell-Mediated Immune Protection against Heterologous Influenza Infection , 2004 .
[57] E. Wherry,et al. Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1 , 2003, The Journal of Immunology.
[58] P. Marrack,et al. CD8 T cell competition for dendritic cells in vivo is an early event in activation , 2006, Proceedings of the National Academy of Sciences.
[59] D. Turner,et al. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. , 2006, Immunity.
[60] Philip R. Johnson,et al. HIV vaccine design: insights from live attenuated SIV vaccines , 2005, Nature Immunology.
[61] H. K. Altes,et al. The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[62] J. Yin,et al. Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.
[63] A. Perelson,et al. High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8+ T-Cell Expansion but Improved Virus Control , 2005, Journal of Virology.
[64] A S Perelson,et al. T cell repertoires and competitive exclusion. , 1994, Journal of theoretical biology.
[65] Takahiro Hirata,et al. Cytotoxic T Lymphocyte–based Control of Simian Immunodeficiency Virus Replication in a Preclinical AIDS Vaccine Trial , 2004, The Journal of experimental medicine.
[66] Bin Li,et al. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. , 2006, Virology.
[67] Rob J. De Boer,et al. Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection , 2006, PLoS Comput. Biol..
[68] Becca Asquith,et al. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. , 2005, The Journal of general virology.
[69] Alan S. Perelson,et al. Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV viral dynamic parameters. , 2001 .
[70] D. Montefiori,et al. ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency , 2002, Journal of Virology.
[71] A. Perelson,et al. Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus , 2004, Journal of Virology.
[72] Athanasius F. M. Marée,et al. Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[73] D. Watkins,et al. Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 , 2002, Journal of Virology.
[74] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[75] David Depoil,et al. Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[76] R. Kaul,et al. HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1 , 2000, The Journal of Immunology.
[77] Alan S Perelson,et al. Estimates of Intracellular Delay and Average Drug Efficacy from Viral Load Data of HIV-Infected Individuals under Antiretroviral Therapy , 2004, Antiviral therapy.
[78] A. Perelson,et al. Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 2000, The Journal of experimental medicine.
[79] Henryk Mach,et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.
[80] Douglas D. Richman,et al. Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.
[81] A. Tzafriri,et al. The total quasi-steady-state approximation is valid for reversible enzyme kinetics. , 2004, Journal of theoretical biology.
[82] Beda Joos,et al. HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death , 2006, Journal of medical virology.
[83] Wayne C Koff,et al. HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.
[84] Elazer R Edelman,et al. On the validity of the quasi-steady state approximation of bimolecular reactions in solution. , 2005, Journal of theoretical biology.
[85] Rustom Antia,et al. Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection , 2004, Journal of Virology.
[86] M. Merkenschlager,et al. Memory T cells , 1989, Nature.
[87] E. Rosenberg,et al. Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.
[88] D. Weiner,et al. Long-Lasting Decrease in Viremia in Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251 after Therapeutic DNA Immunization , 2006, Journal of Virology.
[89] C. Boucher,et al. Anti-CD4 therapy for AIDS suggested by mathematical models , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[90] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.
[91] J. Altman,et al. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.
[92] David Montefiori,et al. An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants , 2001, Cell.
[93] H. Clifford Lane,et al. Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.
[94] H. McClure,et al. Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation , 2003, AIDS.
[95] D. Montefiori,et al. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. , 2005, Virology.
[96] D. Montefiori,et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge , 2006, The Journal of experimental medicine.
[97] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[98] L M Wahl,et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.
[99] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[100] R. Zinkernagel. Immunity, immunopathology and vaccines against HIV? , 2002, Vaccine.
[101] R. Kaul,et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. , 2001, The Journal of clinical investigation.
[102] D. Watkins,et al. CD8+ T-Lymphocyte Response to Major Immunodominant Epitopes after Vaginal Exposure to Simian Immunodeficiency Virus: Too Late and Too Little , 2005, Journal of Virology.
[103] I. M. Rouzine,et al. Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[104] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[105] P. Doherty,et al. Accessing complexity: the dynamics of virus-specific T cell responses. , 2000, Annual review of immunology.
[106] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.